Weifeng Tang
-
- Diabetes Treatment and Management 29
- Diabetes Management and Research 14
-
- Chronic Lymphocytic Leukemia Research 6
-
- Cytokine Signaling Pathways and Interactions 4
-
- Pancreatic function and diabetes 19
-
- Monoclonal and Polyclonal Antibodies Research 6
-
- Systemic Lupus Erythematosus Research 5
-
- Metabolism, Diabetes, and Cancer 4
- Co-authors
- David W. BoultonPatricia McCoonElizabeth R. PlimackGregory A. CurtPatricia LoRussoRobert C. PenlandSabine EckhardtAnnetta Krebs
- Partner nations
- United StatesSwedenPoland
In The Last Decade
Weifeng Tang
51 papers receiving 636 citations
Peers
Comparison fields: 5 of 89
- Endocrinology, Diabetes and Metabolism 262
- Genetics 60
- Oncology 125
- Nephrology 32
- Pharmacology 37
Countries citing papers authored by Weifeng Tang
This map shows the geographic impact of Weifeng Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifeng Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifeng Tang more than expected).
Fields of papers citing papers by Weifeng Tang
This network shows the impact of papers produced by Weifeng Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifeng Tang. The network helps show where Weifeng Tang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weifeng Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 23 | |
| 11 | 2023 | 9 | |
| 12 | 2023 | 0 | |
| 13 | 2023 | 4 | |
| 14 | 2023 | 3 | |
| 15 | 2021 | 3 | |
| 16 | 2018 | 24 | |
| 17 | 2016 | 22 | |
| 18 | 2015 | 12 | |
| 19 | 2014 | 25 | |
| 20 | 1999 | 39 |
About Weifeng Tang
Weifeng Tang is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Nephrology, having authored 58 papers that have together received 649 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (29 papers), Pancreatic function and diabetes (19 papers), Diabetes Management and Research (14 papers), Chronic Lymphocytic Leukemia Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Systemic Lupus Erythematosus Research (5 papers), Metabolism, Diabetes, and Cancer (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (262 citations), Genetics (60 citations) and Oncology (125 citations). Weifeng Tang has collaborated with scholars based in United States, Sweden and Poland. Frequent co-authors include David W. Boulton, Patricia McCoon, Elizabeth R. Plimack, Gregory A. Curt, Patricia LoRusso, Robert C. Penland, Sabine Eckhardt, Annetta Krebs, Joanna Parkinson and Zahir A. Shaikh. Their work appears in journals such as Diabetes Care, Diabetes and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.